ULB - Université libre de Bruxelles has proudly announced a significant achievement in the realm of medical research. Sabine Costagliola, Research Director at FNRS and Director of IRIBHM (ULB), has been honored with the Generet Prize 2023 for Rare Diseases. This prestigious award, totaling €1 million, recognizes her groundbreaking research in the field of rare thyroid disorders.
Costagliola's innovative approach employs human organoid technology to model two specific rare thyroid disorders. This pioneering research not only advances our understanding of these conditions but also holds immense promise for the development of effective treatments.
The Generet Prize serves as a testament to Costagliola's dedication and expertise in her field. Her work exemplifies ULB's commitment to pushing the boundaries of scientific exploration and fostering excellence in healthcare.
Through this groundbreaking research, ULB continues to make significant strides in addressing the challenges posed by rare diseases. The recognition bestowed upon Costagliola underscores the university's position as a leader in medical innovation and underscores its dedication to improving healthcare outcomes for individuals worldwide.
This achievement not only highlights the importance of continued investment in scientific research but also offers hope to those affected by rare thyroid disorders. ULB remains at the forefront of transformative medical discoveries, reaffirming its status as a beacon of excellence in academia and healthcare innovation.